Search research articles
Contact Us
Filters
Showing results (71-80 of 190) with videos related to
Page
of 19
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2011
A USA registry of gastrointestinal stromal tumor patients: changes in practice over time and differences between community and academic practices
P W T Pisters, C D Blanke, M von Mehren, et al.
The Oncologist
|
November 19, 2015
S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors
Charles D Blanke, Cathy Rankin, Christopher Corless, et al.
Journal of the National Cancer Institute
|
April 24, 2018
A New Framework for Patient Engagement in Cancer Clinical Trials Cooperative Group Studies
Patricia A Deverka, Rick Bangs, Karma Kreizenbeck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors
George D Demetri, Yanfeng Wang, Elisabeth Wehrle, et al.
JAMA Network Open
|
May 1, 2020
Association of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive Findings
Joseph M Unger, Charles D Blanke, Michael LeBlanc, et al.
Seminars in Radiation Oncology
|
April 21, 1999
Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancer
C D Blanke, H Choy, M Teng, et al.
Blood
|
April 9, 2004
Serum KIT and KIT ligand levels in patients with gastrointestinal stromal tumors treated with imatinib
Petri Bono, Andreas Krause, Margaret von Mehren, et al.
Clinical Colorectal Cancer
|
August 24, 2011
Survival for metastatic colorectal cancer in the bevacizumab era: a population-based analysis
Daniel J Renouf, Howard J Lim, Caroline Speers, et al.
JAMA Network Open
|
August 10, 2019
Trends in Medical Aid in Dying in Oregon and Washington
Luai Al Rabadi, Michael LeBlanc, Taylor Bucy, et al.
Journal of Surgical Oncology
|
June 26, 2024
Adjuvant imatinib in high-risk resected gastrointestinal stromal tumors: Merely delaying the inevitable?
Thomas L Sutton, Kevin G Billingsley, Alicia J Johnson, et al.
Page
of 19
Search research articles
Search
Showing results (71-80 of 190) with videos related to
Sort By:
Page
of 19
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2011
A USA registry of gastrointestinal stromal tumor patients: changes in practice over time and differences between community and academic practices
P W T Pisters, C D Blanke, M von Mehren, et al.
The Oncologist
|
November 19, 2015
S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors
Charles D Blanke, Cathy Rankin, Christopher Corless, et al.
Journal of the National Cancer Institute
|
April 24, 2018
A New Framework for Patient Engagement in Cancer Clinical Trials Cooperative Group Studies
Patricia A Deverka, Rick Bangs, Karma Kreizenbeck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors
George D Demetri, Yanfeng Wang, Elisabeth Wehrle, et al.
JAMA Network Open
|
May 1, 2020
Association of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive Findings
Joseph M Unger, Charles D Blanke, Michael LeBlanc, et al.
Seminars in Radiation Oncology
|
April 21, 1999
Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancer
C D Blanke, H Choy, M Teng, et al.
Blood
|
April 9, 2004
Serum KIT and KIT ligand levels in patients with gastrointestinal stromal tumors treated with imatinib
Petri Bono, Andreas Krause, Margaret von Mehren, et al.
Clinical Colorectal Cancer
|
August 24, 2011
Survival for metastatic colorectal cancer in the bevacizumab era: a population-based analysis
Daniel J Renouf, Howard J Lim, Caroline Speers, et al.
JAMA Network Open
|
August 10, 2019
Trends in Medical Aid in Dying in Oregon and Washington
Luai Al Rabadi, Michael LeBlanc, Taylor Bucy, et al.
Journal of Surgical Oncology
|
June 26, 2024
Adjuvant imatinib in high-risk resected gastrointestinal stromal tumors: Merely delaying the inevitable?
Thomas L Sutton, Kevin G Billingsley, Alicia J Johnson, et al.
Page
of 19